Commission Regulation (EC) No 1024/2009Show full title

Commission Regulation (EC) No 1024/2009 of 29 October 2009 on the authorisation and refusal of authorisation of certain health claims made on food and referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance)

ANNEX IU.K.

PERMITTED HEALTH CLAIMS

Application — Relevant provisions of Regulation (EC) No 1924/2006Applicant — AddressNutrient, substance, food or food categoryClaimConditions of use of the claimConditions and/or restrictions of use of the food and/or additional statement or warningEFSA opinion reference
Article 14(1)(a) health claim referring to a reduction of a disease riskLeaf Int and Leaf Holland, Hoevestein 26, 4903 SC Oosterhout NB, The Netherlands, and Leaf Suomi Oy, PO Box 25, FI-21381 Aura, FinlandChewing gum sweetened with 100 % xylitolChewing gum sweetened with 100 % xylitol has been shown to reduce dental plaque. High content/level of dental plaque is a risk factor in the development of caries in childrenInformation to the consumer that the beneficial effect is obtained with a consumption of 2-3 g of chewing gum sweetened with 100 % xylitol at least 3 times per day after the mealsQ-2008-321
Article 14(1)(b) health claim referring to children’s development and healthDanone SA, C/Buenos Aires, 21, 08029 Barcelona, SpainPhosphorusPhosphorus is needed for the normal growth and development of bone in childrenThe claim can be used only for food which is at least a source of phosphorus as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006Q-2008-217

ANNEX IIU.K.

REJECTED HEALTH CLAIMS

Application — Relevant provisions of Regulation (EC) No 1924/2006Nutrient, substance, food or food categoryClaimEFSA opinion reference
Article 14(1)(b) health claim referring to children’s development and healthLactoralLactoral helps to bring back the normal functioning of the alimentary tract during its microflora disturbances (for example in case of loose stools, after taking antibiotics, in case of intestinal disorders caused by enteric pathogens)EFSA-Q-2008-269
Article 14(1)(b) health claim referring to children’s development and healthLactoralLactoral is recommended in order to improve the general immunity by maintaining the microbiological balanceEFSA-Q-2008-477
Article 14(1)(b) health claim referring to children’s development and healthLactoralLactoral helps to protect the alimentary system against enteric pathogens because of strong antagonistic properties and helps to build the natural intestinal barrierEFSA-Q-2008-478
Article 14(1)(b) health claim referring to children’s development and healthLactoralLactoral helps to maintain natural intestinal microflora during travel, changing the climatic zone or a diet, especially in poor hygiene conditionsEFSA-Q-2008-479
Article 14(1)(b) health claim referring to children’s development and healthLactoralLactoral contains living probiotic bacteria with strong ability to intestinal tract colonisation, isolated from healthy, naturally fed infantEFSA-Q-2008-480
Article 14(1)(b) health claim referring to children’s development and healthMumomega®Mumomega® provides the nourishments that support healthy central nervous system developmentEFSA-Q-2008-328
Article 14(1)(b) health claim referring to children’s development and healthEfalex®Efalex® may help maintain coordinationEFSA-Q-2008-121
Article 14(1)(b) health claim referring to children’s development and healthEfalex®Efalex® may help maintain concentrationEFSA-Q-2008-317
Article 14(1)(b) health claim referring to children’s development and healthEfalex®Efalex® may help maintain and support brain development and functionEFSA-Q-2008-318
Article 14(1)(b) health claim referring to children’s development and healthEfalex®Efalex® may help maintain learning abilityEFSA-Q-2008-319
Article 14(1)(b) health claim referring to children’s development and healthEfalex®Efalex® may help maintain and support eye development and functionEFSA-Q-2008-320
Article 14(1)(b) health claim referring to children’s development and healthEye q baby®Eye q baby® provides the nourishments that support healthy central nervous system developmentEFSA-Q-2008-119
Article 14(1)(b) health claim referring to children’s development and healthEye q®Eye q® provides the nourishments that help children to maintain healthy brain functionsEFSA-Q-2008-329
Article 14(1)(b) health claim referring to children’s development and healthEye q®Eye q® provides the nourishments that help children to maintain concentration levelsEFSA-Q-2008-330